Autoimmune Diseases
Conference Coverage
SLE flares linked to air temperature, pollution
AMSTERDAM – Rises in temperature and air pollution upped the chances of disease activity flares in patients with systemic lupus erythematosus.
Conference Coverage
CRISS hailed as transforming systemic sclerosis drug development
News
Predicting rituximab responses in lupus remains challenging
Video
New SLE classification criteria reset disease definition
Conference Coverage
JAK inhibitor therapy promising for refractory dermatomyositis
ORLANDO – A pilot study of tofacitinib for refractory dermatomyositis in adults is underway.
Video
SLE classification criteria perform well in validation study
Conference Coverage
LLDAS shows potential as routine lupus treatment target
Video
Baricitinib shows potential as lupus treatment
News
FDA approves rituximab for treating pemphigus vulgaris
Approval was based on a prospective, multicenter, open-label, randomized study conducted in France.
Conference Coverage
Long-term follow-up most important for hydroxychloroquine retinal screening
LIVERPOOL, ENGLAND – The cost of early screening for hydroxychloroquine eye toxicity is likely to be substantial if recent U.K. guidelines are...
Conference Coverage
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
Indeterminate test results can exclude patients from treatment with immunosuppressives and clinical trials.